Novel genetic variants in TP37, PIK3R1, CALM1, and PLCG2 of the neurotrophin signaling pathway are associated with the progression from mild cognitive …
Background: Alzheimer's disease (AD) is a common neurodegenerative disease and mild
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive …
H Li, H Liu, MW Lutz, S Luo - Journal of Alzheimer's Disease: JAD, 2023 - europepmc.org
Background Alzheimer's disease (AD) is a common neurodegenerative disease and mild
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
[PDF][PDF] Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive …
H Lia, H Liub, MW Lutzd, S Luoa - dukespace.lib.duke.edu
Background: Alzheimer's disease (AD) is a common neurodegenerative disease and mild
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive …
H Li, H Liu, MW Lutz, S Luo… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is a common neurodegenerative disease and mild
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
[HTML][HTML] Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive …
H Li, H Liu, MW Lutz, S Luo… - Journal of Alzheimer's …, 2023 - ncbi.nlm.nih.gov
Background: Alzheimer's disease (AD) is a common neurodegenerative disease and mild
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive …
H Li, H Liu, MW Lutz, S Luo - Journal of Alzheimer's Disease: JAD, 2022 - europepmc.org
Background Alzheimer's disease (AD) is a common neurodegenerative disease and mild
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive …
H Li, H Liu, MW Lutz, S Luo… - 2022 - dukespace.lib.duke.edu
Background Alzheimer's disease (AD) is a common neurodegenerative disease and mild
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …
cognitive impairment (MCI) is considered as the prodromal stage of AD. Previous studies …